NCT03321279 (MOVE IT) is a NA clinical trial of Social Incentive in Pneumonia, sponsored by University of Pennsylvania.

Who is sponsoring NCT03321279?

NCT03321279 is sponsored by University of Pennsylvania.

What drugs are being tested in NCT03321279?

Interventions in NCT03321279: Social Incentive.

What condition does NCT03321279 study?

NCT03321279 studies Pneumonia, Diabetes, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease.

Is NCT03321279 still recruiting?

NCT03321279 is currently completed. Last updated 30 July 2020.

Last reviewed 2020-07-30 · How we verify

NCT03321279: MOVE IT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Social Incentives to Increase Mobility

Completed NA Last updated 30 July 2020

What this trial tests

NA trial testing Social Incentive in Pneumonia in 233 participants. Completed in 9 September 2019.

Timeline

11 January 2018

Primary endpoint
9 September 2019

9 September 2019

Quick facts

Lead sponsor	University of Pennsylvania
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	233
Start date	11 January 2018
Primary completion	9 September 2019
Estimated completion	9 September 2019
Sites	1 location across United States

Drugs / interventions tested

Social Incentive

Conditions studied

Pneumonia — all drugs for Pneumonia →
Diabetes — all drugs for Diabetes →
Congestive Heart Failure — all drugs for Congestive Heart Failure →
Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →

Sponsor

University of Pennsylvania

Who can join

18 and older, any sex, with Pneumonia or Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess the effectiveness of a social incentive-based gamification intervention to increase physical activity in the 3 months after hospital discharge.

Publications & conference data

7 peer-reviewed publications reference this trial (live from Europe PMC):

Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD).
Burge AT, Cox NS, Abramson MJ, Holland AE. · · 2020 · cited 87× · PMID 32297320 · DOI 10.1002/14651858.cd012626.pub2
The effectiveness of incentives for research participation: A systematic review and meta-analysis of randomized controlled trials.
Abdelazeem B, Abbas KS, Amin MA, El-Shahat NA, et al · · 2022 · cited 77× · PMID 35452488 · DOI 10.1371/journal.pone.0267534
Effectiveness and Ethics of Incentives for Research Participation: 2 Randomized Clinical Trials.
Halpern SD, Chowdhury M, Bayes B, Cooney E, et al · · 2021 · cited 42× · PMID 34542553 · DOI 10.1001/jamainternmed.2021.5450
Participants' Perspectives on Payment for Research Participation: A Qualitative Study.
Largent EA, Eriksen W, Barg FK, Greysen SR, et al · · 2022 · cited 18× · PMID 36316972 · DOI 10.1002/eahr.500147
Effect of Behaviorally Designed Gamification With a Social Support Partner to Increase Mobility After Hospital Discharge: A Randomized Clinical Trial.
Greysen SR, Changolkar S, Small DS, Reale C, et al · · 2021 · cited 15× · PMID 33760089 · DOI 10.1001/jamanetworkopen.2021.0952
Patient-reported sleep and physical function during and after hospitalization.
Willinger CM, Waddell KJ, Arora V, Patel MS, et al · · 2024 · cited 4× · PMID 38151376 · DOI 10.1016/j.sleh.2023.12.001
Exploring Wearables to Focus on the "Sweet Spot" of Physical Activity and Sleep After Hospitalization: Secondary Analysis.
Greysen SR, Waddell KJ, Patel MS. · · 2022 · cited 1× · PMID 35476034 · DOI 10.2196/30089

Verify or expand the search:

Other trials of Social Incentive

Trials testing the same drug.

NCT04573972 — Using Social Connectedness to Increase Physical Activity · NA · completed

Other recruiting trials for Pneumonia

Currently open trials in the same condition.

NCT07453966 — Efficacy and Safety of Intrapulmonary Percussive Ventilation in Patients With Pulmonary Infection Receiving Invasive Mec · NA · recruiting
NCT07251465 — A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia · active not recruiting
NCT07311343 — Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia · Phase 4 · recruiting
NCT07298889 — High PEEP in Noninvasive Ventilation Patients With Pneumonia or ARDS · NA · recruiting
NCT06911658 — Infectious Complications After Esophagectomy · recruiting

Other University of Pennsylvania trials

Trials by the same sponsor.

NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03321279 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
Last refreshed: 30 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03321279.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing